The recent meeting of the European League Against Rheumatism (EULAR) continued to present more data on the tumor necrosis factor (TNF) inhibitors, Enbrel, Remicade and Humira. And these drugs continue to impress.
However, the jury is out as to whether every rheumatoid arthritis patient needs the TNF drugs. It does appear that more aggressive and creative use of the more traditional drugs used in the treatment of rheumatoid arthritis can be extremely effective also.
The EULAR...
